Investigator

Julien E. Gautrot

Professor of Biomaterials and Biointerfaces · Queen Mary University of London, School of Engineering and Materials Science

About

JEGJulien E. Gautrot
Papers(2)
Biomimetic organo-hyd…Human 3D Ovarian Canc…
Collaborators(10)
Frances R. BalkwillOkan GultekinPanoraia KotantakiRanjit ManchandaSarah HopkinsTwana AlkasaliasAlessandro AnnibaldiBeatrice MalacridaDaniele MarcianoEleni Maniati
Institutions(5)
Queen Mary University…Karolinska InstitutetWolfson Institute of …Unknown InstitutionBarts Cancer Institute

Papers

Human 3D Ovarian Cancer Models Reveal Malignant Cell–Intrinsic and –Extrinsic Factors That Influence CAR T-cell Activity

Abstract In vitro preclinical testing of chimeric antigen receptor (CAR) T cells is mostly carried out in monolayer cell cultures. However, alternative strategies are needed to take into account the complexity and the effects of the tumor microenvironment. Here, we describe the modulation of CAR T-cell activity by malignant cells and fibroblasts in human three-dimensional (3D) in vitro cell models of increasing complexity. In models combining mucin-1 (MUC1) and TnMUC1 CAR T cells with human high-grade serous ovarian cancer cell spheroids, malignant cell–intrinsic resistance to CAR T-cell killing was due to defective death receptor signaling involving TNFα. Adding primary human fibroblasts to spheroids unexpectedly increased the ability of CAR T cells to kill resistant malignant cells as CCL2 produced by fibroblasts activated CCR2/4+ CAR T cells. However, culturing malignant cells and fibroblasts in collagen gels engendered production of a dense extracellular matrix that impeded CAR T-cell activity in a TGFβ-dependent manner. A vascularized microfluidic device was developed that allowed CAR T cells to flow through the vessels and penetrate the gels in a more physiological way, killing malignant cells in a TNFα-dependent manner. Complex 3D human cell models may provide an efficient way of screening multiple cytotoxic human immune cell constructs while also enabling evaluation of mechanisms of resistance involving cell–cell and cell–matrix interactions, thus accelerating preclinical research on cytotoxic immune cell therapies in solid tumors. Significance: Three-dimensional in vitro models of increasing complexity uncover mechanisms of resistance to CAR T cells in solid tumors, which could help accelerate development of improved CAR T-cell constructs.

186Works
2Papers
15Collaborators

Positions

Professor of Biomaterials and Biointerfaces

Queen Mary University of London · School of Engineering and Materials Science

Links & IDs
0000-0002-1614-2578

Scopus: 15022201300

Researcher Id: S-7920-2016